help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Groussin, L.
Right arrow Articles by Bertherat, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Groussin, L.
Right arrow Articles by Bertherat, J.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Adrenal Gland Cancer
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 1 345-354
Copyright © 2000 by The Endocrine Society

Original Studies

Loss of Expression of the Ubiquitous Transcription Factor cAMP Response Element-Binding Protein (CREB) and Compensatory Overexpression of the Activator CREM{tau} in the Human Adrenocortical Cancer Cell Line H295R1

Lionel Groussin, Jean Francis Massias, Xavier Bertagna and Jérôme Bertherat

Groupe d’Etude en Physiopathologie Endocrinienne, Centre National de la Recherche Scientifique, UPR1524, Institut Cochin de Génétique Moléculaire, Université René Descartes-Paris V, 75014 Paris, France

Address all correspondence and requests for reprints to: Jérôme Bertherat, M.D., Ph.D., Groupe d’Etude en Physiopathologie Endocrinienne, Centre National de la Recherche Scientifique, UPR1524, Institut Cochin de Génétique Moléculaire, Centre Hospitalier Universitaire Cochin, 24 rue du Fg. St. Jacques, 75014 Paris, France. E-mail: bertherat{at}icgm.cochin.inserm.fr

The pituitary hormone ACTH, acting through the cAMP pathway, plays a key role in proliferation and differentiation of the adrenal cortex. CAMP response element (CRE)-binding protein (CREB) is an ubiquitous transcription factor that binds to the CRE present in the promoter of numerous genes and mediates transcription stimulation by cAMP. Characterization of CRE-binding proteins was performed in the H295R cell line, which is considered a model for human adrenocortical tumor studies.

Western blot and RT-PCR studies demonstrated that CREB is not expressed in the human adrenocortical cancer cell line H295R, whereas it is expressed in normal adrenal. During transient transfection experiments, cAMP stimulation of two reporter genes containing canonical CRE was maintained. Cotransfection of the dominant negative inhibitor A-CREB, which prevents transcription factors containing a CREB-like leucine zipper domain to bind DNA, completely inhibited cAMP-induced stimulation of CRE activity. Western blot and RT-PCR studies showed that activating transcription factor-1 (ATF-1), CRE modulator-{alpha}/{gamma} (CREM{alpha}/{gamma}), and CREM{tau}2{alpha} are expressed in H295R cells. High amounts of CREM proteins were present in H295R, demonstrating an overexpression of this transcription factor in the absence of CREB. Furthermore, expression of the activator isoform CREM{tau} was very high in H295R compared to normal adrenal cortex. Transfection assays demonstrated that CREM{tau}2{alpha} is a potent stimulator of CRE activity in H295R. Finally, gel retardation assays showed that CREM and ATF-1 are the nuclear proteins that specifically bind the CRE in H295R cells, whereas CREM binding to CRE is not observed in a CREB-expressing cell line.

H295R cells are the first established nontransgenic cell line that does not express the ubiquitous transcription factor CREB. H295R demonstrates that CREM{tau} up-regulation can compensate for CREB deficiency to maintain CRE regulation by cAMP and is a model of compensation mechanisms between the members of the CREB/CREM/ATF-1 family of transcription factors. This loss of CREB expression and the overexpression of CREM could be linked to cellular transformation, as the normal adrenal cortex express high levels of CREB and no or low levels of CREM{tau}.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
B. Ragazzon, L. Cazabat, M. Rizk-Rabin, G. Assie, L. Groussin, H. Fierrard, K. Perlemoine, A. Martinez, and J. Bertherat
Inactivation of the Carney Complex Gene 1 (Protein Kinase A Regulatory Subunit 1A) Inhibits SMAD3 Expression and TGF{beta}-Stimulated Apoptosis in Adrenocortical Cells
Cancer Res., September 15, 2009; 69(18): 7278 - 7284.
[Abstract] [Full Text] [PDF]

Home page
 DTBHome page
Testosterone patches for female sexual dysfunction
DTB, March 1, 2009; 47(3): 30 - 34.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. Rizk-Rabin, G. Assie, F. Rene-Corail, K. Perlemoine, H. Hamzaoui, F. Tissier, M. Lieberherr, X. Bertagna, J. Bertherat, and Z. Bouizar
Differential Expression of Parathyroid Hormone-Related Protein in Adrenocortical Tumors: Autocrine/Paracrine Effects on the Growth and Signaling Pathways in H295R Cells
Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2275 - 2285.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
O Gubbay, M T Rae, A S McNeilly, F X Donadeu, A J Zeleznik, and S G Hillier
cAMP response element-binding (CREB) signalling and ovarian surface epithelial cell survival.
J. Endocrinol., October 1, 2006; 191(1): 275 - 285.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
T. Sugawara, N. Sakuragi, and H. Minakami
CREM confers cAMP responsiveness in human steroidogenic acute regulatory protein expression in NCI-H295R cells rather than SF-1/Ad4BP.
J. Endocrinol., October 1, 2006; 191(1): 327 - 337.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
R. Libe and J. Bertherat
Molecular genetics of adrenocortical tumours, from familial to sporadic diseases
Eur. J. Endocrinol., October 1, 2005; 153(4): 477 - 487.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. Tissier, C. Cavard, L. Groussin, K. Perlemoine, G. Fumey, A.-M. Hagnere, F. Rene-Corail, E. Jullian, C. Gicquel, X. Bertagna, et al.
Mutations of {beta}-Catenin in Adrenocortical Tumors: Activation of the Wnt Signaling Pathway Is a Frequent Event in both Benign and Malignant Adrenocortical Tumors
Cancer Res., September 1, 2005; 65(17): 7622 - 7627.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. de Fraipont, M. El Atifi, N. Cherradi, G. Le Moigne, G. Defaye, R. Houlgatte, J. Bertherat, X. Bertagna, P.-F. Plouin, E. Baudin, et al.
Gene Expression Profiling of Human Adrenocortical Tumors Using Complementary Deoxyribonucleic Acid Microarrays Identifies Several Candidate Genes as Markers of Malignancy
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1819 - 1829.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
J Liu, X-D Li, A Ora, P Heikkila, A Vaheri, and R Voutilainen
cAMP-dependent protein kinase activation inhibits proliferation and enhances apoptotic effect of tumor necrosis factor-{alpha} in NCI-H295R adrenocortical cells
J. Mol. Endocrinol., October 1, 2004; 33(2): 511 - 522.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Bertherat, L. Groussin, F. Sandrini, L. Matyakhina, T. Bei, S. Stergiopoulos, T. Papageorgiou, I. Bourdeau, L. S. Kirschner, C. Vincent-Dejean, et al.
Molecular and Functional Analysis of PRKAR1A and its Locus (17q22-24) in Sporadic Adrenocortical Tumors: 17q Losses, Somatic Mutations, and Protein Kinase A Expression and Activity
Cancer Res., September 1, 2003; 63(17): 5308 - 5319.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Gu, Y. Wen, A. Mison, and J. L. Nadler
12-Lipoxygenase Pathway Increases Aldosterone Production, 3',5'-Cyclic Adenosine Monophosphate Response Element-Binding Protein Phosphorylation, and p38 Mitogen-Activated Protein Kinase Activation in H295R Human Adrenocortical Cells
Endocrinology, February 1, 2003; 144(2): 534 - 543.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J.-F. Louet, G. Hayhurst, F. J. Gonzalez, J. Girard, and J.-F. Decaux
The Coactivator PGC-1 Is Involved in the Regulation of the Liver Carnitine Palmitoyltransferase I Gene Expression by cAMP in Combination with HNF4alpha and cAMP-response Element-binding Protein (CREB)
J. Biol. Chem., October 4, 2002; 277(41): 37991 - 38000.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Doi, H. Takemori, X.-z. Lin, N. Horike, Y. Katoh, and M. Okamoto
Salt-inducible Kinase Represses cAMP-dependent Protein Kinase-mediated Activation of Human Cholesterol Side Chain Cleavage Cytochrome P450 Promoter through the CREB Basic Leucine Zipper Domain
J. Biol. Chem., May 3, 2002; 277(18): 15629 - 15637.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Bailey, R. J. Phillips, A. J. Pollard, K. Gilmore, S. C. Robson, and G. N. Europe-Finner
Characterization and Functional Analysis of cAMP Response Element Modulator Protein and Activating Transcription Factor 2 (ATF2) Isoforms in the Human Myometrium during Pregnancy and Labor: Identification of a Novel ATF2 Species with Potent Transactivation Properties
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1717 - 1728.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society